There is currently no national screening programme for the disease in the UK Oncologica has developed a urine-based screening test for prostate cancer and has launched a funding drive to support its ...

Leeds Teaching Hospitals NHS Trust (LTHT) has announced that it is piloting a new artificial intelligence (AI) and machine learning software system for prostate cancer diagnosis. Working in ...

The conference will return to Vienna AirportCity on 23 to 24 October 2024 Samedan has announced that on 23 to 24 October 2024, its FlyPharma Conference will make a welcome return to Office Park 4, ...

Alchemab Therapeutics has appointed Jane Osbourn, the company’s Co-Founder and Chief Scientific Officer, as Chief Executive ...

The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley as Acting President. Abberley, who is General Manager of Amgen UK and Ireland, has over 25 years of life ...

This month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our industry. Our insightful front cover article delves into the key regulatory ...

World Sepsis Day, observed annually on 13 September, aims to raise awareness about sepsis, a life-threatening condition that claims millions of lives each year. Sepsis results from a dysregulated ...

Chemistry is the cornerstone of modern civilisation, playing a crucial role in virtually every aspect of our lives. From the food we eat and the water we drink to the medicines which save lives and ...

Nxera Pharma and Cancer Research UK are set to present their ongoing Phase 1/2a clinical trial of the cancer immunotherapy drug HTL0039732 at the European Society for Medical Oncology (ESMO) Congress ...

Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has announced that its partner, Centessa Pharmaceuticals, has reported encouraging ...

A recent study published in the American Journal of Psychiatry suggests that menopausal hormone therapy (HRT) may reduce the risk of psychosis relapse in menopausal women. The research, led by Bodyl ...